Unnamed: 0
int64
0
10k
title
stringlengths
3
547
abstract
stringlengths
10
122k
9,500
Contents-cover detailsi
null
9,501
Posters
null
9,502
K.01 Emerging viruses: From clinical virology to virus ecology
null
9,503
PIN12 - HOSPITALIZATIONS RELATED TO RESPIRATORY VIRAL INFECTIONS DURING THE 2017/18 SEASON IN THE VALENCIA REGION OF SPAIN
null
9,504
PP-182 Systematic study the clinic characters of a local measles outbreak in East China
null
9,505
Hepatobiliary & Pancreatic Diseases International (HBPD Int). Table of Contents Vol. 4, No. 1, 2005
null
9,506
Subject index (vol. 90)
null
9,507
THE RETROSPECTIVE ANALYSIS OF GLUCOCORTICOSTEROIDS USE IN THE TREATMENT OF SARS IN BEIJING
null
9,508
Coronaviruses and their diseases. Advances in experimental medicine and biology, Volume 276: Edited by D. Cavanagh & T. D. K. Brown. New York and London: Plenum Press. 1990. 676 pp. US$155.40
null
9,509
FEBS Letters
null
9,510
Infection precautions
null
9,511
Comparison of enzyme-linked immunosorbent assay and western blotting in the detection of anticryptosporidial antibodies in the investigation of a waterborne outbreak of cryptosporidiosis
null
9,512
List of Contents, Author, and Keyword Indices, Vol 29, 2005
null
9,513
Contents of Volume 143
null
9,514
Asian–Oceanian textbook of radiology: By W. C. G. Peh and Y. Hiramatsu. Hardcover, 1300 pp. TTG Asia Media, Singapore, 2003. Price US$120, €98
null
9,515
Pyogranulomatous Pleuropneumonia and Mediastinitis in Ferrets Associated with Chryseomonas-like Bacteria
null
9,516
Exercise Limitation in Survivors of Severe Acute Respiratory Syndrome (SARS)
null
9,517
Community-Acquired Respiratory Virus Infections During the First Year After Lung Transplantation
null
9,518
Keyword Index
null
9,519
Respiratory Infection Routes of MERS-CoV in Rabbits
null
9,520
P241 Validation of APPS tool to predict mortality in moderate and severe acute respiratory distress syndrome
null
9,521
Keyword Index
null
9,522
To Disclose the Anti-Infection/Inflammatory Mechanism of Terpenoids From Houttuynia Cordata in Virtue of Molecular Simulation
null
9,523
Contents of Volume 151
null
9,524
CHARACTERISTICS AND OUTCOMES AMONG PATIENTS WITH RESPIRATORY VIRUS INFECTIONS DURING THE FIRST YEAR AFTER LUNG TRANSPLANTATION
null
9,525
The veterinary formulary. Handbook of medicines used in veterinary practice: Edited by Yolande Debuf London: The Pharmaceutical Press. 1991. 448 pp. £37.50 (hard)
null
9,526
Pulmonary Function in Survivors of Severe Acute Respiratory Syndrome (SARS)
null
9,527
PULSED METHYLPREDNISOLONE USAGE IN ARDS DUE TO VIRAL PNEUMONIA
null
9,528
The Use of Drotrecogin Alfa (activated) in a Patient With Severe Acute Respiratory Syndrom
null
9,529
Binding and entry of animal viruses
Viruses are infectious agents capable of packaging and delivering nucleic acids and proteins to specific populations of cells. To initiate infection, viruses bind to sites, or receptors, on the cell surface and transfer their genome across the limiting membrane of the cell. The mechanisms underlying these events, and viral tropism for particular host cells, are becoming increasingly well understood. Several cell surface proteins have now been identified as viral receptors, and analyses of intact virus particles and sub-viral components are revealing the structures of the binding determinants on the viruses themselves. For many viruses, the events leading to penetration and delivery involve constitutive endocytic properties of the host cell, and the low pH environment in endocytic compartments is a crucial trigger in the penetration process. The knowledge of viral tropism, binding and entry suggests strategies which may be applied to the design of targeted therapeutic agents with appropriate specificities and effective delivery mechanisms.
9,530
Techniques for the Brucellosis laboratory: G. G. Alton, L. M. Jones, R. D. Angus & J. M. Verger Versailles Cedex: INRA Publications. 1988. 192pp. Ff 195
null
9,531
The role of Cryptosporidium parvum-derived phospholipase in mediating enteric host cell invasion in vitro
null
9,532
Author index to volume 87
null
9,533
Flu: The Story of the Great Influenza Pandemic of 1918 and the Search for the Virus That Caused It
null
9,534
Infection and immunity in farm animals: Edited by R. Pandey Basel: S. Karger. 1985. 255 pp. SFr. 164
null
9,535
Subject Index: TO FOLLOW
null
9,536
SUBJECT INDEX Volume 125 (JANUARY–JUNE, 2004)
null
9,537
Imaging in SARS
null
9,538
Viral Infections and Inflammatory Bowel Disease
null
9,539
Master Author Index
null
9,540
Contents and index of volume 113, July to November 1995
null
9,541
Comparison of the Mortality Prediction of Different ICU Scoring Systems (APACHE II and III, SAPS II, and SOFA) in Acute Respiratory Distress Syndrome Patients
null
9,542
DASATINIB-RELATED CHYLOTHORAX
null
9,543
Cumulative subject index volumes 24–25
null
9,544
Enteric viral infection in patients with the acquired immunodeficiency syndrome: A case of diarrhea?
null
9,545
Liquid column chromatography
null
9,546
Animal health 1984—Report of the chief veterinary officer: London: HMSO. 159 pp. £9.30
null
9,547
Anaesthesia and Intensive Care A-Z–An Encyclopaedia of Principles and Practice
null
9,548
IMAGINATION OF THE IMAGES WHEN VIRUSES ATTACK THE LUNGS
null
9,549
Abstracts of Papers Submitted to the American Gastroenterological Association
null
9,550
High Dose Intravenous Methylprednisolone in the Treatment of Severe Acute Respiratory Syndrome: A Case Repor
null
9,551
Cell Tropism of Middle East Respiratory Syndrome Coronavirus in Experimentally Infected Dromedaries
null
9,552
Anesthesia and Uncommon Diseases
null
9,553
AGA abstracts T1786–W1189
null
9,554
Primum Non Nocere
null
9,555
Corrigendum to “Individual and common inhibitors of coronavirus and picornavirus main proteases” [FEBS Lett. 583 (2009) 549–555]
null
9,556
Tissue Distribution of the Mers-Coronavirus Receptor in Bats
null
9,557
Evolution and tumor pathology of the neuroendocrine system. Fernström foundation series
null
9,558
Master Subject Index
null
9,559
The Novel Human Coronavirus EMC Causes Disease in Macaques but not in Ferrets
null
9,560
Campylobacter infection in man and animals
null
9,561
Toxicological evaluation of certain veterinary drug residues in food: Prepared by The 36th Meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA). WHO food additive series: 27 Geneva: WHO 1211 Geneva 27, Switzerland/London: HMSO Books. 1991. 227 pp. Sw.fr. 25. (paper)
null
9,562
Effect of human recombinant interferon-γ on Salmonella typhimurium invasion in cultured human intestinal cells
null
9,563
Nonbacterial respiratory infections
null
9,564
An Uncommon Cause of Adult Respiratory Distress Syndrome
null
9,565
Horses in health and disease: J. L. Naviaux Philadelphia: Lea and Febiger/Beckenham, Kent: Quest-Meridien Ltd. 1985. 300 pp. $27
null
9,566
THE LONG-TERM IMPACT OF SEVERE ACUTE RESPIRATORY SYNDROME (SARS) ON PULMONARY FUNCTION, EXERCISE CAPACITY, AND QUALITY OF LIFE IN A COHORT OF SURVIVORS
null
9,567
The First Outbreak of Porcine Epidemic Diarrhoea in Slovenia: A Signal of Emerging Disease?
null
9,568
Contents and index of volume 119, july to november 1998
null
9,569
Imaging in SARS
null
9,570
In Brief
null
9,571
Contents of volume 87
null
9,572
Contents of Volume 138
null
9,573
Bovine Histophilosis in Southern Brazil
null
9,574
Mers Coronavirus Infection in Dromedary Camels
null
9,575
Subject index to volume 104
null
9,576
Subject index to volume 87
null
9,577
Contents of Volumes 166 to 173
null
9,578
Virus diseases in laboratory and captive animals: Edited by Gholamreza Darai Dordrecht: Martinus Nijhoff/Kluwer Academic Publishers. 1988. 568 pp. £96.50
null
9,579
Cumulative subject index volumes 52–53
null
9,580
RARE CASE OF MORTALITY FROM NON-CIRRHOTIC HYPERAMMONEMIA
null
9,581
The EMPOWER-SUSTAIN e-Health Intervention to improve patient activation and self-management behaviours among individuals with Metabolic Syndrome in primary care: study protocol for a pilot randomised controlled trial
BACKGROUND: Epidemiological studies conducted in various parts of the world have clearly demonstrated that metabolic syndrome (MetS) is an increasing global health problem, not only in Western societies but also in Asian populations. Web-based and mobile phone-based self-management applications have been proven to be effective in improving self-management behaviour of patients with MetS components (i.e., diabetes or hypertension). However, evidence is lacking in terms of their effectiveness specifically for patients with MetS. The aim of this pilot study is to evaluate the feasibility and potential effectiveness of the EMPOWER-SUSTAIN Self-Management e-Health Intervention in improving activation and self-management behaviours among patients with MetS. This paper presents the study protocol. METHODS: A pilot randomised controlled trial will be conducted in a university primary care clinic. A total of 232 patients aged 18–60 years with MetS will be recruited; 116 will be randomised to receive the EMPOWER-SUSTAIN intervention for 6 months, and another 116 patients will continue with usual care. The EMPOWER-SUSTAIN intervention is a multifaceted chronic disease management strategy based on the Chronic Care Model and persuasive technology theory. It consists of training primary care physicians, nurses and patients to use the EMPOWER-SUSTAIN web-based self-management mobile app, strengthening the patient–physician relationship and reinforcing the use of relevant clinical practice guidelines to guide management and prescribing. The primary outcome is the mean change in patient activation score using the Patient Activation Measure short form Malay version (PAM-13-M) questionnaire. The secondary outcomes include the changes in waist circumference, body mass index, blood pressure, patient physical activity level, eating behaviour, perception of chronic illness care, satisfaction with patient–physician interaction, and perceived absolute 10-year cardiovascular disease risk. Feasibility of implementing the intervention will be evaluated. This includes acceptability of the intervention, estimating the likely rate of participant recruitment and retention, appropriateness of the outcome measures, calculation of sample size, and the intervention’s potential effectiveness. CONCLUSION: To our knowledge, this is the first study in Malaysia that aims to determine the feasibility of a multifaceted e-health intervention, as well as to indicate more useful aspects of this intervention for further exploration in a larger trial. TRIAL REGISTRATION: ClinicalTrials.gov, NCT04120779. Registered on 9 October 2019, protocol version 1.
9,582
Contents of volume 301 (2005)
null
9,583
adr-type hepatitis B virus surface antigen for vaccine production obtained by culture of human hepatoma cell strain huGK-14
null
9,584
New dengue virus Type-1 strain; recombinant DEN1 protein expression; potential in recombinant vaccine construction, virus detection and dengue fever diagnosis and therapy
null
9,585
Recombinant DNA encoding hepatitis B virus polypeptide antigen is used in detection of infection and in vaccine production; production in prokaryotic or eukaryotic host; core antigen, surface antigen DNA sequence
null
9,586
Genetically engineered vaccines for mycobacterial antigens comprising recombinant poxvirus, e.g. vaccinia virus, capable of expressing Mycobacterium leprae, Mycobacterium tuberculosis or Mycobacterium bovis antigens
null
9,587
Bordetella bronchiseptica vaccine production by fermentation under specified conditions
null
9,588
¿Qué ha cambiado en la neumonía adquirida en la comunidad en los últimos años?
null
9,589
Issue TOC
null
9,590
JINF – Posters
null
9,591
Cumulative subject index volumes 168–173
null
9,592
Ribavirine : au revoir VHC, bonjour VHE
null
9,593
Subject index: Volume 32, 1999
null
9,594
Enteric viruses in a cohort of rural costa rican children()
null
9,595
Pathology of the Fischer Rat — Reference and Atlas
null
9,596
Isolated specific epitope region of thyroid peroxidase; for use as a recombinant vaccine in thyroid tumour or Hashimoto disease immunotherapy
null
9,597
Subject index for volume 190
null
9,598
Cumulative subject index volumes 69–75
null
9,599
Lead level in edible macromycetes in NW spain as biomarker in ecotoxicology
null